CDC anthrax vaccine safety & efficacy research program : interim report /
Anthrax in its inhalational form is a deadly but very rare manifestation of infection with a common organism, Bacillus anthracis. Anthrax spores are very stable, a characteristic that makes possible their delivery as a weapon of biological warfare, and examples of weapons development efforts using a...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Washington, DC :
National Academy Press,
[2001]
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover
- Copyright
- Table of Contents
- Preface
- Acknowledgments
- REVIEWERS
- Executive Summary
- PROJECT-SPECIFIC FINDINGS AND RECOMMENDATIONS
- NCID-Directed Projects in the Research Program
- NIP-Directed Projects of the Research Program
- 1 Introduction and Background
- ANTHRAX DISEASE AND PREVENTION
- Anthrax Disease
- Anthrax Vaccine
- VACCINE RELATED ADVERSE EVENTS
- POLICY CONTEXT OF REPORT
- Anthrax Vaccination Policy
- CDC'S REPONSE TO CONGRESS
- 2 Interim Findings and Recommendations
- NCID RESEARCH ACTIVITIES
- Part A: Clinical Trial
- Part B: Non-human Primate Dose-Ranging and Challenge Study
- Part C: Assays of Immunologic Correlates of Protection
- NIP RESEARCH ACTIVITIES
- Knowledge, Attitudes, and Beliefs of Military Personnel about the Anthrax Vaccine
- Knowledge, Attitudes, and Beliefs of Vaccine Providers about VAERS Reporting
- Data Mining Using the VAERS Database
- Meta-Analysis of Existing Studies on the Anthrax Vaccine
- REFERENCES
- ACRONYMS
- Appendix A Study Activities.